An Interview with Mara Hvistendahl
In an interview with The Wire's David Barboza, author Mara Hvistendahl talks about her book "The Scientist and the Spy," and the impact of industrial...
Showing 1297 - 1305 of 1305
Decoding the Covid-19 Downturn
Our roundup of China news and insights you may have missed: Economic lamentation. Small-business unrest in Wuhan. Billionaire’s movie dream in peril. TikTok has ByteDance...
Is America’s Antibiotic Supply at Risk?
The United States no longer produces crucial drugs like penicillin. Instead, China, a strategic rival, now dominates the world’s supply chain. With a global pandemic...
In High-Stakes Chip Deal, China Has Regulatory Leverage
A strategic struggle over tech supremacy frames Nvidia’s pending acquisition of Mellanox.
How Soon Can China’s Economy Rebound?
Our roundup of the China news you may have missed this week: Creative accounting scandals are back. Consumers are weighed down by debt. The Central...
Essential New Reading on China
Welcome to the Books Wire — our monthly page bringing you a smorgasbord of essential new reads on China.
Winston Lord on U.S.–China Cooperation During Covid-19
A veteran diplomat explains why the problems with China pre-date Trump and how the U.S. can pursue smart competition.
These Days, Every Story Is a China Story
We're covering China like no one else, and every week, our award-winning journalists will bring you original, in-depth reporting on some of the biggest stories...
China’s Antibiotics Dominance
By some estimates, 90 percent of the world’s supply of antibiotics originate at huge factories in China.